“heart-failure” Archives

Entry Author Date Location
After Rival Stumbles, Relypsa Gets $1.5B Buyout Bid From Galenica 07/21/16 San Francisco
With $40M Led by GV, Quartet Expands Tech for Mental Health Care 04/14/16 New York
West Coast Bio Roundup: CRISPR Patent, HCV Data, Verily Digs & More 02/19/16 San Francisco
Dallas-Fort Worth Aims to Boost Life Sciences Ecosystem 10/05/15 Texas
BioCardia Files for $50M IPO for Cell-Based Cardiovascular Therapies 07/06/15 San Francisco
Behavioral-Health Focused Quartet Plans Hires With $7M Series A 04/02/15 New York
West Coast Biotech Roundup: Apple, 23andMe, Amgen, Acadia & More 03/13/15 San Francisco
Hatch Pitch Unveils Tech Startup Lineup for Upcoming SXSW Demo Day 02/11/15 Texas
Celladon Gets FDA’s “Breakthrough Therapy” Status for Gene Therapy 04/10/14 San Diego
Backed By a Billionaire, Berg Pharma Aims to Speed Drugmaking 04/02/14 Boston
Houston Medtech Firm Procyrion Aims to Help Heart Heal Itself 03/25/14 Texas
San Diego’s Celladon Sets Price Range for IPO Shares 11/05/13 San Diego
UW Spinout, Beat Bio, Gets $2.5M to Treat Heart Failure 04/16/13 Seattle
CardioKinetix Clears 2-Year Study with Implant for Heart Failure 05/18/12 San Francisco
CircuLite Attracts Big Support for Tiny Heart-Assist Device 01/05/12 New York
Ambrx Grabs $24M Upfront in New Diabetes, Heart Failure Research Deal With Bristol-Myers 09/22/11 San Diego
BG Medicine Chief Speaks on Rough IPO Climate, (Finally) Going Public 04/21/11 Boston
HeartWare Gets $143.8M in Debt Offering 12/15/10 Boston
BG Medicine Wins FDA OK, Primes Pump for Second Shot at IPO 11/24/10 Boston
Feds’ Sequenom Probe Breaks Into the Open, Life Technologies Moves Into Synthetic Biology, DexCom Agrees to Re-Label Its Medical Devices, & More San Diego Life Sciences News 06/03/10 San Diego
Ending the Suspense, Celladon’s Gene Therapy Helps Heart Failure Patients in Small Study 06/01/10 San Diego
NormOxys Pockets $17.5M for Drugs Against Heart Failure, Cancer 05/24/10 Boston
Cytori Heartened by Cell Therapy in Two Small Studies of Cardiac Patients 05/07/10 San Diego
Celladon’s Gene Therapy Passes Heart Failure Trial; Maintains Suspense on Details 04/28/10 San Diego
QuantumCor Sees Future of Heart Failure Treatment in No Device Left Behind 11/02/09 Seattle
Celladon CEO Upbeat on Gene Therapy for Heart 05/29/09 San Diego
Targeted Genetics, Mainstay of Gene Therapy, Faces Likely Shutdown 05/07/09 Seattle
Targeted Genetics Hands Off Manufacturing 03/02/09 Seattle
Pathway Medical Gets Traction, Ekos Raises $12.5M, ZymoGenetics Sales Boss Departs, & More Seattle-Area Life Sciences News 02/05/09 Seattle
Cardiac Dimensions Wins European Clearance to Sell Device for Heart Failure 01/29/09 Seattle
Page 1 of 2 next page »